# David J. Glass elected to the U.S. National Academy of Sciences

**Authors:** Se-Jin Lee, Bruce Spiegelman, Kevin Campbell

PMC · DOI: 10.1186/s13395-024-00343-5 · 2024-07-09

## Full-text entities

- **Genes:** ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, MSTN (myostatin) [NCBI Gene 2660] {aka GDF8, MSLHP}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, FBXO32 (F-box protein 32) [NCBI Gene 114907] {aka Fbx32, MAFbx}, GDF11 (growth differentiation factor 11) [NCBI Gene 10220] {aka BMP-11, BMP11, VHO}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, TRIM63 (tripartite motif containing 63) [NCBI Gene 84676] {aka CMH31, IRF, MURF1, MURF2, RNF28, SMRZ}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, PI3 (peptidase inhibitor 3) [NCBI Gene 5266] {aka ESI, SKALP, WAP3, WFDC14, cementoin}
- **Diseases:** Aging/ (MESH:D019588), hypertrophy (MESH:D006984), Age-Related Disorders (MESH:D008569), obese (MESH:D009765), muscle hypertrophy (MESH:C536106), type 2 diabetes (MESH:D003924), muscle atrophy (MESH:D009133), atrophy (MESH:D001284)
- **Chemicals:** Novartis (MESH:C014635), bimagrumab (MESH:C000596367), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

---
Source: https://tomesphere.com/paper/PMC11232304